TGen, George Mason Launch Precision Medicine Alliance | GenomeWeb

NEW YORK (GenomeWeb) – The Translational Genomics Research Institute and George Mason University today said that they will integrate genomics, proteomics, and molecular profiling in an alliance aimed at finding personalized treatments for patients.

The TGen-George Mason Molecular Medicine Alliance will pair TGen's genomics capabilities with research carried out at George Mason's Center for Applied Proteomics and Molecular Medicine. Their goal is to apply and study personalized methods for treating patients with cancer and other life-threatening conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."